Summary: Recent research clarifies how far lifestyle changes can go to prevent cognitive decline across different genetic backgrounds. The study assessed modifiable risk factors (mRF)—including physical activity, blood pressure control, and other lifestyle and vascular factors—and how they interact with the APOE ε4 genotype, a principal genetic risk factor for Alzheimer’s disease.
The analysis shows that a healthy lifestyle is associated with substantially lower dementia risk and less structural brain damage in people who carry zero or one copy of the APOE ε4 allele. However, the same protective association was not observed in individuals who carry two copies of APOE ε4 (homozygotes); for them, dementia risk and MRI markers of brain injury remained high regardless of lifestyle profile.
Key Facts
- Study population: Researchers evaluated 9,605 community-dwelling Japanese adults aged 65 and older to assess how genetic risk and modifiable lifestyle factors jointly influence dementia risk.
- Risk rises with allele count: Dementia odds increased steadily with the number of APOE ε4 alleles. Individuals with two copies of the allele had over a tenfold higher dementia risk compared with noncarriers.
- Lifestyle impact for most people: Among participants with zero or one APOE ε4 allele, lower mRF scores—reflecting healthier habits and better vascular health—were associated with significantly reduced dementia risk.
- Limited effect in homozygotes: For individuals with two APOE ε4 alleles, dementia risk remained high and did not differ significantly between those with favorable versus unfavorable lifestyle profiles.
- MRI supports the findings: Brain scans showed that healthier mRF profiles correlated with less brain atrophy and fewer white matter lesions in noncarriers and heterozygotes, whereas homozygotes showed advanced atrophy and extensive white matter damage irrespective of lifestyle.
- Public health implication: With global dementia cases projected to rise sharply by 2050, these results support a move from one-size-fits-all guidance toward interventions tailored by genetic risk.
- Clinical implications: Lead investigator Professor Toshiharu Ninomiya emphasizes that standard lifestyle and vascular risk management is effective for noncarriers and single-allele carriers, but those with two APOE ε4 alleles may need earlier medical screening and novel preventive or therapeutic approaches beyond lifestyle modification.
Source: Kyushu University
As dementia prevalence climbs worldwide, identifying effective prevention strategies is a public health priority. Lifestyle measures such as regular physical activity, blood pressure control, healthy diet, smoking cessation, and diabetes management are known to influence dementia risk. Yet the extent to which these modifiable risk factors protect people across different genetic profiles—especially those with high inherited risk—has been unclear.
Published on May 21 in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring, the study led by Kyushu University and RIKEN evaluated whether favorable modifiable risk factors lower dementia risk even among those with high genetic susceptibility. The researchers derived an mRF score from lifestyle and vascular variables, determined APOE ε4 genotype for each participant, and examined clinical dementia diagnoses and brain MRI measures in a subset.
Consistent patterns emerged. Dementia odds rose with APOE ε4 allele count: noncarriers fared best, heterozygotes intermediate, and homozygotes faced the highest risk. Crucially, lower mRF scores correlated with reduced dementia odds and preserved brain structure in noncarriers and heterozygotes. In contrast, homozygous carriers showed no meaningful benefit from favorable lifestyle profiles—both dementia prevalence and MRI indicators of brain injury were similarly elevated across lifestyle categories.
MRI evidence reinforced the clinical observations. In participants with zero or one ε4 allele, healthier mRF profiles were linked to reduced global brain atrophy and fewer white matter lesions—markers that commonly predict cognitive decline. Those with two ε4 alleles had advanced brain atrophy and widespread white matter damage regardless of their mRF scores, suggesting that in homozygotes genetic factors may dominate over modifiable influences.
These findings have two important implications. At the population level, they reinforce the value of lifestyle and vascular risk management as effective prevention strategies for most older adults, especially those without the highest genetic risk. At the clinical level, they indicate that individuals who inherit two APOE ε4 alleles may require a different approach—earlier and more intensive surveillance, and preventive or therapeutic options that go beyond classical lifestyle interventions.
Key Questions Answered:
A: No. The study shows that people who carry two copies of APOE ε4 do not experience a measurable reduction in dementia risk or MRI markers of brain damage from a favorable lifestyle, unlike noncarriers and single-allele carriers.
A: Yes. Individuals with one APOE ε4 allele benefit from healthier lifestyles: they show lower dementia risk, less brain atrophy, and fewer white matter lesions compared with peers with higher mRF scores.
A: Earlier medical screening and advanced preventive or therapeutic strategies. Because conventional risk-factor management appears insufficient to offset the high genetic risk in homozygotes, the study authors recommend exploring targeted clinical measures and next-generation interventions.
Editorial Notes:
- This summary was edited by an editorial team with expertise in neuroscience reporting.
- The underlying journal paper was reviewed in full to ensure accurate reporting of results and conclusions.
- Additional explanatory context was added to help readers understand clinical and public health implications.
About this genetics and dementia research news
Author: Qinlin Wu
Source: Kyushu University
Contact: Qinlin Wu – Kyushu University
Image: Image credit to Neuroscience News
Original Research: Closed access. “APOE ε4, modifiable risk factors and dementia in community-based older Japanese adults” by Masaya Kumamoto et al. Published in Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. DOI: 10.1002/dad2.70371
Abstract
APOE ε4, modifiable risk factors and dementia in community-based older Japanese adults
INTRODUCTION
Apolipoprotein E (APOE) ε4 is a major genetic risk factor for dementia. This study investigated whether APOE ε4 genotype modifies the association between a composite modifiable risk factor score and dementia in older Japanese adults.
METHODS
This cross-sectional analysis included 9,605 community-dwelling Japanese participants aged 65 years or older. Researchers determined APOE ε4 genotype and calculated mRF scores from lifestyle and vascular health measures. Dementia diagnoses were clinical, and brain MRI measures were available for a subgroup.
RESULTS
Dementia odds increased with the number of APOE ε4 alleles. Lower mRF scores were associated with reduced odds of prevalent dementia and with more preserved brain structure in noncarriers and heterozygotes, but these associations were not observed in homozygotes.
DISCUSSION
A favorable modifiable risk profile was linked to lower dementia risk and preserved brain anatomy in participants without or with a single APOE ε4 allele, but not in those with two alleles. These results support prevention strategies tailored by genotype, and highlight the need for alternative approaches for individuals with the highest genetic risk.